Little is known about the burden of common mental disorders in Russia despite high levels of suicide and alcohol-related mortality. Here we investigated levels of symptoms, self-reports of ever having received a diagnosis and treatment of anxiety and depression in two Russian cities. The study population was men and women aged 35–69 years old participating in cross-sectional population-based studies in the cities of Arkhangelsk and Novosibirsk (2015–18). Participants completed an interview which included the PHQ-9 and GAD-7 scales, questions on whether participants had ever received a diagnosis of depression or anxiety, and health service use in the past year. Participants also reported current medication use and medications were coded in line with the WHO anatomical therapeutic classification (ATC). Depression was defined as PHQ-9 ≥ 10 and Anxiety as GAD-7 ≥ 10. Age-standardised prevalence of PHQ-9 ≥ 10 was 10.7% in women and 5.4% in men (GAD-7 ≥ 10 6.2% in women; 3.0% in men). Among those with PHQ-9 ≥ 10 17% reported ever having been diagnosed with depression (equivalent finding for anxiety 29%). Only 1.5% of those with PHQ-9 ≥ 10 reported using anti-depressants and 0.6% of those with GAD-7 ≥ 10 reported using anxiolytics. No men with PHQ-9 ≥ 10 and/or GAD-7 ≥ 10 reported use of anti-depressants or anxiolytics. Use of health services increased with increasing severity of both depression and anxiety. There was a large gap between symptoms and reporting of past diagnosis and treatment of common mental disorders in two Russian cities. Interventions aimed at improving mental health literacy and reducing stigma could be of benefit in closing this substantial treatment gap.

中文翻译：

---

在俄罗斯两个城市的一般人群中，症状的发生率，曾经接受过抑郁症和焦虑症的诊断和治疗以及与卫生服务的使用相关

尽管自杀和酒精相关的死亡率很高，但对俄罗斯常见精神障碍的负担知之甚少。在这里，我们调查了两个俄罗斯城市的症状水平，曾经接受过焦虑和抑郁症诊断和治疗的自我报告。研究对象是年龄在35-69岁之间的男性和女性，他们在阿尔汉格尔斯克州和新西伯利亚市参加了基于人群的横断面研究（2015-18年）。参与者完成了一次访谈，其中包括PHQ-9和GAD-7量表，关于参与者是否曾在过去一年中被诊断出患有抑郁症或焦虑症的问题以及对医疗服务的使用的问题。参与者还报告了目前的药物使用情况，并且药物的编码符合WHO的解剖学治疗分类（ATC）。抑郁症定义为PHQ-9≥10，焦虑症定义为GAD-7≥10。按年龄标准划分，女性的PHQ-9≥10患病率为10.7％，男性为5.4％（GAD-7≥10 6.2％为女性； 3.0 ％（男性）。在PHQ-9≥10的患者中，据报告曾经被诊断出患有抑郁症（焦虑症的平均发现率为29％）。据报道，PHQ-9≥10的患者使用抗抑郁药的比例仅为1.5％，而GAD-7≥10的患者使用抗焦虑药的比例为0.6％。没有PHQ-9≥10和/或GAD-7≥10的男性报告使用抗抑郁药或抗焦虑药。随着抑郁症和焦虑症的严重程度增加，对医疗服务的使用也增加了。俄罗斯两个城市的症状与过去诊断和治疗常见精神障碍的报告之间存在很大差距。